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Sunuan Twenty-six cases of Kaposi's sarcoma (KS) were recorded by the New South Wales Central Cancer
Registry between 1972 and 1982. prior to the first AIDS diagnoses in Australia. The overall annual incidence
was 0.47 per million. Incidence was three times higher in males. The highest incidence was in people born in
the Middle East and in males born in southern and eastern Europe.
Before Kaposi's sarcoma (KS) appeared. in the early 1980s.
as one of the most distinctive manifestations of the acquired
immunodeficiency syndrome (AIDS) (Centers for Disease
Control. 1981), it was already considered to have some
unique epidemiological features. Most striking were an
association between KS and specific ethnic origin (Bluefarb.
1957). relatively high frequency in parts of Africa (Cook &
Burkitt. 1971) and increased incidence in patients who had
received immunosuppressive treatment following renal or
other transplantation (Kinlen. 1982).
Even among people infected with human immuno-
deficiency virus (HIV). the causal agent for AIDS. KS does
not occur randomly. It is much more likely to develop in
men who acquired HIV infection through homosexual con-
tact than in other subgroups of people with HIV infection.
suggesting the role of a sexually transmissible agent apart
from HIV (Beral et al.. 1990). Interest in evaluating this
hypothesis. combined with the recognition that much of the
earlier descriptive work on KS occurrence did not involve
population-based data collection. has led to detailed re-
examination of cancer registry reports of KS incidence prior
to the AIDS epidemic (Biggar et al., 1984: Ross et al., 1985;
Dictor & Attewell. 1988; Grulich et al.. 1992).
In this paper. we describe the incidence of KS in New
South Wales. Australia's most populous state. from 1971 to
1982.
Materials and methods
Roughly one-third of Australia's population of 17 million
lives in New South Wales, and over 3.5 million people live in
Sydney. the capital of New South Wales and Australia's
largest city. The state's proportion of foreign-born residents
(23%) is similar to that of Australia as a whole (Australian
Bureau of Statistics, 1991). New South Wales has also been
the focal point for the AIDS epidemic in Australia (Kaldor
et al.. 1993).
The New South Wales Central Cancer Registry, estab-
lished in 1972. was the first population-based monitoring
system for cancer in Australia (Coates et al.. 1992). State
legislation in that year mandated the notification of all diag-
noses of malignant disease (apart from non-melanoma skin
cancer) by hospitals, radiotherapists and nursing homes. and
from 1985 by pathologists. In addition, death certificates
mentioning cancer have been routinely reviewed since the
Registry's establishment. Cancer registrations include date of
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diagnosis, date of birth, sex. country of birth and site and
histological type of malignancy. Marital status is recorded on
death certificates, but not cancer notifications.
All cases of KS in New South Wales residents reported to
the Registry from 1972 to 1982 (the year of the first AIDS
diagnosis in Australia) were included in the study. Incidence
rates specific for age. sex. country of birth and calendar
period were calculated using population estimates published
by the Australian Bureau of Statistics (1990). Countries of
birth were grouped as indicated in Table II. and incidence by
country of birth was standardised for age and sex to the
world population using the direct method (Breslow & Day,
1987). Confidence intervals for directly standardised rates
were calculated using the method proposed by Dobson et al.
(1991). For registered cases of KS. the New South Wales
Registry of Deaths was searched to determine whether the
patient was recorded as having died in New South Wales.
Results
During the study period. 26 cases of KS were reported to the
New South Wales Cancer Registry. The incidence of KS in
New South Wales. by age group. sex and two separate
calendar periods is reported in Table I. The overall crude
annual incidence was 0.47 per million. Incidence was over
twice as high in males as in females, and increased with age
in both sexes. When two calendar periods of registration.
1972-76 and 1977-82, were compared, there appeared to be
little difference in incidence for females between the periods
(0.33 per million in the earlier period vs 0.26 in the later
period). but for males there was a marked increase (0.33 vs
0.91 per million). The biggest increment was in men aged 65
or older, but there was also an increase in the age group
15-39.
There was a substantial difference in incidence rates of KS
Table I Registration rate of KS per million by age group, sex and
calendar period, New South Wales. 1972-82 (number of cases)
Age group (years}
0-14 15-39 40-59 60 + All ages
Males
1972-76 0 (0) 0.21 (1) 0.73 (2) 0.61 (1) 0.33 (4)
1977-82 0 (0) 0.45 (3) 0.59 (2) 4.7 (9) 0.91 (14)
1972-82 0 (0) 0.36 (4) 0.65 (4) 2.8 (10) 0.65 (18)
Females
1972-76 0 (0) 0 (0) 0.74 (2) 1.1 (2) 0.33 (4)
1977-82 0 (0) 0.16 (1) 0 (0) 1.3 (3) 0.26 (4)
1972-82 0 (0) 0.094 (1) 0.34 (2) 1.2 (5) 0.29 (8)
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Table II Age-adjusted registration rate of KS per million population by sex and region of birth. New South Wales
1972-82
.Male Female
Cases Cases
Region ofbirth 1972-76 1977-82 Rate0 95% CI 1972-76 1977-82 Rate' 95% CI
Australia. 1 5 0.29 0.072-0.76 2 0 0.089 0.0047-0.41
UK and Ireland
Southern Europeb 2 4 8.2 1.8-22 0 0 - -
Eastern Europe' 0 4 12 1.1-42 1 0 0.94 0.0049-7.0
Middle Eastd 1 1 9.3 0-45 0 2 30 0-160
Other unknown 0 0 - - 1 2- -
aOver the period 1972-82. bCyprus. Greece. Italy. Malta. Portugal. Spain. former Yugoslavia. 'Bulgaria. former
Czechoslovakia. Hungary. Poland. Romania. former Soviet Union. dEgpt. Iran. Iraq. Israel. Lebanon. Syria. Turkey.
by country of birth. as indicated in Table II. KS occurred
with the highest incidence among both males and females
born in countries of the Middle East. and in males of
southern and eastern European origin. It was notable that of
the six male patients born in Australia or the UK. all but one
were diagnosed in 1977 or later. Furthermore. five of these
six patients were in the age range 15-44. and were younger
at the diagnosis of KS than all other cases in males.
Of the 26 patients. 17 were recorded as having died: seven
within 5 years of KS diagnosis. a further seven within 10
years. and the other three over 10 years after diagnosis.
Marital status was available only from the death certificates.
and of the 17 patients reported to have died. 11 males and
four out of five females were recorded as married. widowed
or divorced. None of the recently diagnosed younger men
were reported to have died. so their marital status remained
unknown.
Discussion
The recorded incidence of KS in New South Wales was
about three times higher than the rate recorded in England
and Wales (Grulich et al.. 1992). but an order of magnitude
lower than rates reported from the US (Biggar et al.. 1984)
and Sweden (Dictor & Attewell. 1988) over similar time
periods.
KS incidence in New South Wales was about three times
higher in males than in females. A similar ratio was recorded
for the US (Biggar et al.. 1984) and Sweden (Dictor &
Attewell. 1988), prior to the AIDS epidemic. but not for the
UK (Grulich et al.. 1992). where incidence did not differ by
sex. Incidence increased with age in both males and females.
With the relatively small number of cases recorded. it is
difficult to interpret incidence patterns by age and sex within
regions of birth. However, it appeared that the ratio of male
to female incidence was far higher for people born in count-
ries of the Mediterranean than for those born in other
regions. All six Mediterranean patients were males. while half
the other 12 patients born outside Australia and the UK
were females. In the UK (Grulich et al., 1992). again based
on very few cases within each region. male predominance
only occurred among people born in Africa and the Carib-
bean (eight cases in males vs two in females, against expected
numbers of 0.28 for both males and females).
The variation in KS incidence by country of birth within
Australia is striking, and consistent with earlier findings from
England and Wales (Grulich et al.. 1992). probably the only
other cancer registration area in the world with sufficient
diversity in countries of birth and duration of cancer registra-
tion to be able to produce population-based incidence
estimates of the kind reported in Table II. While diagnostic
differences might be an explanation for a portion of the
between-country variation, it is not plausible that such sub-
stantial differences within a single registry would be
accounted for by biases of this nature.
The picture of the international variation in KS incidence
prior to the appearance of HIV infection is incomplete
because of the absence of population-based registries in many
parts of the world. It is nevertheless clear that populations of
predominantly British origin were exposed to a far lower risk
of KS than populations of many countries in Europe. Africa
and the Caribbean.
Marital status in men has been used as a crude marker for
sexual orientation in some studies (Bernstein et al.. 1989).
Based on the limited information available from this study.
there is no indication that never-married men were at higher
risk of KS prior to the AIDS epidemic, a finding which is
consistent with the corresponding study in England and
Wales (Grulich et al.. 1992).
There was a marked increase in KS incidence from the first
to the second calendar period of observation among men.
but not among women. The increase appeared in both men
born in Australia and the UK and men born elsewhere. In
Sweden. KS incidence increased several-fold in both males
and females between the 1960s and the 1970s. well before the
HIV epidemic began (Dictor & Attewell. 1988). Population-
based estimates of KS incidence are not available for any
part of Australia prior to 1972. The first case of AIDS in
Australia was reported in December 1982. and Kaposi's sar-
coma in a person with AIDS was not reported until 1983
(Kaldor et al.. 1993). It is possible that the increase in KS
incidence among men was due to unrecognised HIV infec-
tion. A more detailed review of the medical records of people
with KS may provide an indication of whether or not HIV
was implicated.
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